There may be renewed hope for people with untreatable cancers. According to a report published by the BBC on Friday, patients have had their immune system…
Vaccine rates for COVID-19 show that the majority of adults accept immunization for themselves while hesitant for their children. Why?
In a disgusting move, cybercriminals published the personal medical details of individual patients to the internet this week.
When Courtney “CJ” Johnson pulls up footage from her Ph.D. dissertation, it’s like she’s watching an attempted break-in on a home security camera.
The intruder cases its target without setting a foot inside, looking for a point of entry. But this intruder is not your typical burglar. It’s a virus.
Continue reading “Watch a virus in the moments right before it attacks” »
Babies born with infantile-onset Pompe disease typically have enlarged hearts and weak muscles. But 1-year-old Ayla has a normal heart and walks.
If QPX9003 makes it through Phase II and III clinical trials and onto the market, it will be the first new lipopeptide antibiotic that targets Gram-negative bacteria in over 60 years.
QPX9003, a new antibiotic for Gram-negative bacteria, has achieved success in a Phase I clinical trial.
Similar to a mouse racing through a maze, making “yes” or “no” decisions at every intersection, researchers have developed a way for machines to swiftly learn all the twists and turns in a complex data system.
“Our method may help improve the diagnosis of urinary diseases, the imaging of cardiac conditions and analysis of financial risks,” reported Abd-AlRahman Rasheed AlMomani of Embry-Riddle Aeronautical University’s Prescott, Arizona, campus.
The research was accepted for the Nov. 11 edition of the journal Patterns with Jie Sun and Erik Bollt of Clarkson University’s Center for Complex Systems Science. The goal of the work is to more efficiently analyze binary (“Boolean”) data.
ISRIB, a tiny molecule identified by University of California, San Francisco (UCSF) researchers can repair the neural and cognitive effects of concussion in mice weeks after the damage, according to a new study.
ISRIB blocks the integrated stress response (ISR), a quality control process for protein production that, when activated chronically, can be harmful to cells.
The study, which was recently published in the Proceedings of the National Academy of Sciences, discovered that ISRIB reverses the effects of traumatic brain injury (TBI) on dendritic spines, an area of neurons vital to cognition. The drug-treated mice also showed sustained improvements in working memory.
A toddler is thriving after doctors in the U.S. and Canada used a novel technique to treat her before she was born for a rare genetic disease that caused the deaths of two of her sisters.
Ayla Bashir, a 16-month-old from Ottawa, Ontario, is the first child treated as a fetus for Pompe disease, an inherited and often fatal disorder in which the body fails to make some or all of a crucial protein.
My good friend Logan collins posted this.
Gene therapies can scale economically, but not just with practices adapted from traditional biologics. According to Avantor, gene therapies pose unique material, workflow, and partnering challenges.
